| Message: | Product Description：
Safe Delivery Powder Raloxifene Hydrochloride (Raloxifene HCl) CAS: 82640-04-8 Anti-Estrogen Serm
Quick Details:
Raloxifene hydrochloride
Raloxifene hydrochloride--Alias: Raloxifene hydrochloride,Raloxifene HCl
Raloxifene hydrochloride--CAS Registry Number: 82640-04-8
Raloxifene hydrochloride--Assay: 99%
Raloxifene hydrochloride--Molecular Formula: C28H28ClNO4S
Raloxifene hydrochloride--Molecular weight: 510.05
Raloxifene hydrochloride--Appearance: white crystalline powder
Raloxifene hydrochloride--Grade:Pharmaceutical Grade
Raloxifene hydrochloride-- Usage:
Amino acid, nutrient.A nonsteroidal, selective estrogen receptor modulator (serm).Antiosteoporotic. A nonsteroidal, selective estrogen receptor modulator (SERM). Antiosteoporotic.
Description :
Raloxifene hydrochloride is a selective estrogen receptor modulator (SERM); acts as an anti-estrogen in both breast and uterine tissue while being estrogenic in bone. May have efficacy against estrogen-sensitive cancers.
Applications :
May prevent or treat corticosteroid-induced bone loss. American College of Rheumatology states that raloxifene can be offered to selected postmenopausal corticosteroid-treated women who refuse hormone replacement therapy or other antiresorptive agents or in whom such therapies are contraindicated.
Reduction in the incidence of invasive breast cancer inpostmenopausal women at high risk for developing the disease. Effect comparable to that of tamoxifen in reducing the risk of invasive breast cancer (STAR trial). No effect on the risk of lobular carcinoma in situ or ductal carcinoma in situ (STAR trial).
|
my account
